Neurotechnology SIG Webinar Series: Developing the UK’s Neurotechnology Capabilities
This is the third webinar in the series, brought to you by the KTN’s Neurotechnology Special Interest Group (SIG).
Neurotechnology is an incredibly multidisciplinary endeavour, covering areas as diverse as fundamental neuroscience, bioelectronic engineering, artificial intelligence and materials science. There are also a number of intellectual property and regulatory stages that need to be passed to get a new neurotechnology innovation to market. It is likely, therefore, that many companies will not have all these areas covered in house.
The featured leading centres are:
Commercial Development Manager – MedTech, Centre for Process Innovation (CPI)
Their expertise covers the entire development cycle, supporting you from initial concept through to adoption of your device in healthcare. Their scientific teams provide the most suitable technical support, helping you overcome your specific challenges. CPI brings you complementary resources to support your existing capabilities and ensure the full potential of your medtech innovation is realised.
Reader (Associate Professor)
University of Manchester, The Henry Royce Institute
This is the UK’s national institute for advanced materials research and innovation. From equipment access for commercially sensitive research to long-term partnerships, the Royce can work flexibly and support a range of approaches and needs.
Dr. Anne Vanhoestenberghe
The Manufacture of Active Implant and Surgical Instruments (MAISI)
King’s College, London School of Biomedical Engineering & Imaging Sciences, in partnership with UCL and Newcastle University, received a Wellcome grant of £5.2 million to establish a new facility for the Manufacture of Active Implant and Surgical Instruments (MAISI), which will be located at St Thomas’ Hospital.